Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 February 2023 | Story Dr Ina Gouws | Photo Supplied
Dr Ina Gouws
Dr Ina Gouws is a Senior Lecturer: Programme: Governance and Political Transformation in the Department of Political Studies and Governance, University of the Free State (UFS)

Opinion Article by Dr Ina Gouws, Senior Lecturer: Programme: Governance and Political Transformation, Department of Political Studies and Governance, University of the Free State.
The State of the Nation Address (Sona) of 2023 is upon us. What can South Africans look forward to in this address this year? According to the Presidency, the President will focus on the energy crisis and the rolling blackouts. He will hopefully also shed some light on the disaster legislation government intends to implement to address the energy crisis. Reports that the ANC wants Dr Nkosazana Dlamini-Zuma to oversee the load-shedding state of disaster does not inspire confidence at the onset. What we should take serious note of is what the President will have to say about the plans to move Eskom to the Department of Mineral Resources and Energy; a move widely criticised and frankly, feared. 

No new policies, focus on resolving policy implementation failures

Also, according to the Presidency, the outcomes of the Investing in Africa Mining Indaba taking place from 7 February 2023, will receive attention in the Sona. This event attracts more than 6 000 delegates comprising comprising investors, innovators, companies in the mining and natural resources sector etc. No doubt the President will paint a picture of substantial investments to look forward to which will lead to job creation, development, and growth; a promise made in every Sona of every year of his term without fail, for which there has been very little evidence. 

The Minister in the Presidency, Mondli Gungubele, also told the media that government will not look to introduce new policies but focus on resolving existing policy implementation failures since this is the final year of this government’s term. 

Other than these areas of focus, we can surely expect the usual stats and figures to indicate “progress” or evidence of a caring government; more people receiving social grants instead of no longer needing this assistance, and entirely unrealistic job creation numbers to name two. Collapsing municipalities and ongoing corruption will also probably get mentioned under the umbrella of service delivery with futile promises of eradicating corruption and appointing qualified cadres. This administration’s score card of the past four years justifies cynicism. 

From what I have heard among fellow South Africans and seen on social media, the interest in the Sona is at an all-time low because of the miseries mentioned. We are tired of politicians talking, promising, stating the obvious (a particular skill our President has polished) and blatantly underestimating our collective intelligence. We KNOW there is no concrete plan to address the energy crisis. We SEE incompetent ministers still have jobs. Promises for growth and job creation do not resonate at all because South Africans LIVE THE REALITY of unemployment and poverty. South Africans cannot be blamed when the idea of sitting through an address covering more of the same with no expectation of positive change is something we are not prepared to do.

Indifference towards Sona 2023

Does this indifference towards the Sona this year necessarily mean that the nation has lost interest in politics in general? Many would argue that this is indeed the case. I do not agree. The abject apathy that is taking hold of (especially young) South Africans concerning our country’s formal political processes is an issue widely researched and debated. Apathy is essentially having no feeling or connection to a situation or a complete lack of desire or interest to act or participate. Youth find the formal political processes frustrating, alienating, and less likely to yield desired results, consequently the evident apathy. More and more older South Africans are joining them in these attitudes and therefore have developed feelings of apathy of their own. However, apathy towards the formal political process and politicians (elections and electorates) does not mean that South Africans are not interested in politics in general. To be indifferent is to decide to show no interest and to not care or have any opinion about an issue, situation, or event. It differs from apathy because sufferings, experience and disappointment breeds apathy which is therefore not a decision, but a condition. Indifference towards the Sona 2023 is a decision South Africans make, but their interest, involvement and participation in civic organisations and representative processes remains vibrant. Therein lies our strength and in my opinion, the revitalisation of grassroots influence on South African politics. 

So, if you have better things to do on the evening of the 9 February 2023, go and do them. Spend the time with community members talking about what can be done where you live to help each other and hold your officials accountable. It might also be your group’s turn for a blackout, so spend the precious time with loved ones around a candle or that rechargeable LED light. Do not feel any guilt or that you are missing out. You are not apathetic, merely indifferent. An understandable choice.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept